How Is The Market Feeling About Vertex Pharmaceuticals?
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals (NYSE:VRTX) has seen a decrease in short interest, with the short percent of float dropping 9.01% since the last report. The company has 2.60 million shares sold short, which is 1.01% of available shares for trading. The average time to cover these short positions is 2.09 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Vertex has a lower short interest compared to its peer group average of 4.19%.
November 14, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vertex Pharmaceuticals's short interest has decreased, suggesting a more bullish sentiment among investors. The company's short interest is below the peer group average, potentially indicating a positive outlook.
A decrease in short interest typically suggests that investors are less bearish on the stock, which could lead to a short-term increase in the stock price. Vertex's lower short interest compared to its peers further supports a potentially positive impact on the stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80